Nuveen Asset Management LLC Sells 29,548 Shares of CME Group Inc. (NASDAQ:CME)

Nuveen Asset Management LLC reduced its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 801,895 shares of the financial services provider's stock after selling 29,548 shares during the quarter. Nuveen Asset Management LLC owned about 0.22% of CME Group worth $186,224,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CME. SJS Investment Consulting Inc. grew its position in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after buying an additional 97 shares during the period. New Age Alpha Advisors LLC raised its stake in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period. Financial Life Planners acquired a new stake in shares of CME Group in the fourth quarter worth $32,000. Knuff & Co LLC acquired a new stake in CME Group during the 4th quarter valued at $33,000. Finally, Banque Transatlantique SA acquired a new stake in CME Group during the 4th quarter valued at $35,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $272.56, for a total transaction of $817,680.00. Following the transaction, the director now directly owns 5,400 shares in the company, valued at approximately $1,471,824. This represents a 35.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Hilda Harris Piell sold 3,984 shares of the company's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the sale, the insider now directly owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This trade represents a 12.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 26,434 shares of company stock valued at $6,987,065 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

Shares of CME stock traded up $1.65 during midday trading on Monday, reaching $277.94. 1,617,773 shares of the company were exchanged, compared to its average volume of 2,179,403. The company's 50 day moving average price is $265.86 and its two-hundred day moving average price is $247.33. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The company has a market cap of $100.16 billion, a P/E ratio of 28.74, a PEG ratio of 6.76 and a beta of 0.45. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $286.48.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.50 EPS. On average, sell-side analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.80%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research analyst reports. UBS Group increased their price objective on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research note on Friday, April 25th. Royal Bank of Canada restated a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Barclays raised their price target on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Keefe, Bruyette & Woods raised their price target on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Finally, Oppenheimer raised their price target on shares of CME Group from $269.00 to $279.00 and gave the stock an "outperform" rating in a research report on Friday, April 11th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $256.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.